uracil and 9,10-dimethyl-1,2-benzanthracene

uracil has been researched along with 9,10-dimethyl-1,2-benzanthracene in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kudo, H; Maemura, M; Mitamura, T; Nakayama, T; Sakamoto, S; Sassa, S; Suzuki, S; Yoshimura, S	1
Iino, Y	1

Other Studies

2 other study(ies) available for uracil and 9,10-dimethyl-1,2-benzanthracene

Article	Year
1-(2-Tetrahydrofuryl)-5-fluorouracil in combination with uracil suppresses mammary carcinogenesis and growth of tumors induced with 7,12-dimethylbenz[a]anthracene in rats. Anti-cancer drugs, 1996, Volume: 7, Issue:2 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bromodeoxyuridine; Female; Hormones; Immunohistochemistry; Incidence; Mammary Neoplasms, Experimental; Organ Size; Rats; Rats, Sprague-Dawley; Tegafur; Thymidine Kinase; Thymidylate Synthase; Uracil	1996
Treatment of tamoxifen-refractory breast cancer--approach by animal models. Breast cancer (Tokyo, Japan), 2001, Volume: 8, Issue:4 Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cyclohexanes; Disease Models, Animal; Female; Mammary Neoplasms, Experimental; Mice; Mice, Nude; O-(Chloroacetylcarbamoyl)fumagillol; Picibanil; Prognosis; Rats; Receptors, Estrogen; Risk Assessment; Sesquiterpenes; Tamoxifen; Tegafur; Treatment Failure; Uracil	2001

Article

Year

1-(2-Tetrahydrofuryl)-5-fluorouracil in combination with uracil suppresses mammary carcinogenesis and growth of tumors induced with 7,12-dimethylbenz[a]anthracene in rats.

Anti-cancer drugs, 1996, Volume: 7, Issue:2

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bromodeoxyuridine; Female; Hormones; Immunohistochemistry; Incidence; Mammary Neoplasms, Experimental; Organ Size; Rats; Rats, Sprague-Dawley; Tegafur; Thymidine Kinase; Thymidylate Synthase; Uracil

1996

Treatment of tamoxifen-refractory breast cancer--approach by animal models.

Breast cancer (Tokyo, Japan), 2001, Volume: 8, Issue:4

Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cyclohexanes; Disease Models, Animal; Female; Mammary Neoplasms, Experimental; Mice; Mice, Nude; O-(Chloroacetylcarbamoyl)fumagillol; Picibanil; Prognosis; Rats; Receptors, Estrogen; Risk Assessment; Sesquiterpenes; Tamoxifen; Tegafur; Treatment Failure; Uracil

2001